Tender detail
Conclusion of a non-exclusive rebate agreement for granisetron
Summary
The tender concerns the conclusion of a non-exclusive rebate agreement for medicines containing the active substance granisetron for the period from 1 August 2026 to 31 July 2028, with an option to extend the contract once by 12 months. Bidders should note that the agreement covers only the active substance Granisetron and the ILO dosage form. The exact participation and contract performance requirements must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.